Within digital infrastructure, Perkins described continued momentum in data centers driven by AI-related capex demand. He said CyrusOne had its "best year ever," including "around half a gigawatts worth of bookings." He also cited the Vantage "Stargate" development announcement, a joint venture between OpenAI and Oracle described as "around 2.5 GW of compute." Perkins said the last year's portfolio shifts were driven by the new investment in Intersect Power and valuation gains at Calpine , which increased N ...

汉莎航空拒绝了工会提出的将公司养老金计划翻倍的要求，称其"荒谬且不可行"。 ...

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Hola Prime, the rapidly growing prop trading firm known for its industry-first 1-Hour Payout model, today announced it has surpassed 1,000 verified reviews on Trustpilot, achieving an Excellent rating of 4.5 out of 5. The milestone positions Hola Prime among the most reviewed and the highest-rated prop trading firms globally on the world's most trusted consumer review platform. This recognition adds to a series of recent industry accolades for the firm, including ...

China Licensing Deal Drives The agreement aims to develop and commercialize pevifoscorvir sodium for chronic hepatitis B virus (HBV) infection in Greater China, which is expected to enhance its market position significantly. Aligos Therapeutics operates as a clinical-stage biotechnology company developing therapies for liver and viral diseases. The deal includes an upfront milestone payment of $25 million and potential additional milestones totaling up to $420 million, as well as tiered royalties on net sal ...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Caring Brands Inc. (NASDAQ: CABR) resulting from allegations that Caring Brands may have issued materially misleading business information to the investing public. So what: If you purchased Caring Brands securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a. ...

中基健康产业股份有限公司 2025年度营业收入扣除情况的 专项审核意见 1. 营业收入扣除情况表 目 录 一、审核意见 二、审核意见附送 中兴华会计师事务所(特殊普通合伙) 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地 址 （ l o c a t i o n ） ： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 2 0 层 20/F,Tower B,Lize SOHO,20 Lize Road,Fengtai District,Beijing PR China 电 话 （ t e l ） ： 0 1 0 - 5 1 4 2 3 8 1 8 传 真 （ f a x ） ： 0 1 0 - 5 1 4 2 3 8 1 6 ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：10007 ...

中基健康产业股份有限公司 内部控制审计报告书 一、中基健康对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评 价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是中基健康董事 会的责任。 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地 址 （ l o c a t i o n ）： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 2 0 层 20/F,Tower B,Lize SOHO,20 Lize Road,Fengtai District,Beijing PR ...

中基健康产业股份有限公司 2025年度财务报表出具非标准无保留意见 审计报告的专项说明 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地 址 （ l o c a t i o n ）： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 2 0 层 20/F,Tower B,Lize SOHO,20 Lize Road,Fengtai District,Beijing PR China 电 话 （ t e l ）： 0 1 0 - 5 1 4 2 3 8 1 8 传 真 （ f a x ）： 0 1 0 - 5 1 4 ...

中基健康产业股份有限公司 2025年度合并及母公司财务报表 审计报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO B 座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 目 录 一、审计报告 二、审计报告附送 1. 合并资产负债表 2. 合并利润表 3. 合并现金流量表 4. 合并股东权益变动表 5. 母公司资产负债表 6. 母公司利润表 7. 母公司现金流量表 8. 母公司股东权益变动表 9. 财务报表附注 三、审计报告附件 1. 中兴华会计师事务所（特殊普通合伙）营业执照复印件 2. 中兴华会计师事务所（特殊普通合伙）执业证书复印件 3. 注册会计师执业证书复印件 中兴华会计师事务所（特殊普通合伙） 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L ...

Keurig Dr Pepper, Inc (KDP) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on April 23, might help the stock move higher if these key numbers are better than ...